Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...

KUWAIT CITY, Nov 10: Minister of Health Dr. Ahmad Al-Awadhi on Monday affirmed that the third expansion of the National Bank ...

SightMD New Jersey is proud to welcome Modupe Adetunji, MD, a highly accomplished ophthalmologist, to its expanding team of leading eye care specialists. Dr. Adetunji brings with her a wealth of ...

The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with ...

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related ...

For more than three decades, USF Distinguished University Professor Dmitry Goldgof in the Bellini College of Artificial ...

Clinician-scientists at St. Jude Children's Research Hospital and collaborators have conducted the largest study of infant-type hemispheric glioma (IHG) ever reported, uncovering key factors that ...

The standard of care in cancer, adopted in the 1990s, is built on consensus based clinical research over large patient populations. However, if we know biologically each person is unique, then a ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

President Trump’s 2025 executive order establishing artificial intelligence (AI) in pediatric cancer as a national priority marks a turning point in medicine. For decades, childhood cancer treatments ...